E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
about
E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformationCellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcriptionNetwork calisthenics: control of E2F dynamics in cell cycle entryMolecular mechanisms underlying RB protein functionThe E2F2 transcription factor sustains hepatic glycerophospholipid homeostasis in miceTargeting the RB-E2F pathway in breast cancerEmerging links between E2F control and mitochondrial functionTranscriptional control of stem cell fate by E2Fs and pocket proteinsControl of cell cycle transcription during G1 and S phasesAtypical E2F repressors and activators coordinate placental developmentE2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional ProgramCanonical and atypical E2Fs regulate the mammalian endocycleRepression by RB1 characterizes genes involved in the penultimate stage of erythroid developmentCytoplasmic-nuclear trafficking of G1/S cell cycle molecules and adult human β-cell replication: a revised model of human β-cell G1/S controlLargazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells.Targeting tumor suppressor networks for cancer therapeutics.Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansionEKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiationMultiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1The retinoblastoma tumor suppressor regulates a xenobiotic detoxification pathway.Integrated transcriptome and binding sites analysis implicates E2F in the regulation of self-renewal in human pluripotent stem cells.A role for SUV39H1-mediated H3K9 trimethylation in the control of genome stability and senescence in WI38 human diploid lung fibroblastsLrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling.G1 arrest and differentiation can occur independently of Rb family function.Direct interaction between causative genes of DYT1 and DYT6 primary dystonia.E2f1-3 are critical for myeloid development.Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model.Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysisEmerging roles of E2Fs in cancer: an exit from cell cycle controlpVHL acts as a downstream target of E2F1 to suppress E2F1 activity.The heterogenic final cell cycle of chicken retinal Lim1 horizontal cells is not regulated by the DNA damage response pathwayReversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4a.Targeting Rb inactivation in cancers by synthetic lethality.E2F inhibition synergizes with paclitaxel in lung cancer cell linesEWS-FLI1 employs an E2F switch to drive target gene expression.Hypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis.Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection.
P2860
Q24296966-58562678-44FF-4539-8858-3D87B7A51ABBQ24299494-91682636-63CD-4EBF-AB1A-0D91BE2B0559Q24306110-6FF86B61-187D-4182-A637-04554AC72C5BQ26824409-DAC1D444-8BC7-44BA-B133-D6C38B501F4FQ27003956-BFA04C73-DA9E-4261-8859-D5A612A1F3A8Q27329136-4C67C239-CF22-4799-9A45-519D9F875338Q28069626-9DF8E6A6-D3D5-403A-ADCA-6362ABF76FE6Q28082267-48FD8C75-BAFA-4A7A-A77F-53BD823E76B6Q28082523-1C650F4B-7901-4372-8B3E-481E201FF8EDQ28295030-279291CE-58A2-4A0B-836F-F43E2F895BB9Q28508978-0C154F20-6D93-4219-A888-C3335F0D524DQ28547821-9F8A75FD-0552-4D66-BA11-147EA5C00CCFQ28585165-DC48E56C-4B00-4619-9067-02A7FBBA39C4Q28600992-06A47C5C-B0EF-4BD5-9F7D-AF66547FF079Q30541505-33C50B97-A1ED-4551-9988-EE170E81B9DCQ33636007-A0705BD2-FAD0-443D-869E-5C22BA8F326AQ33657519-74A38197-FFA7-4565-9518-66F7BFE3D6C5Q33797859-600BC904-D117-45BF-B31D-19BEF6F42984Q33877028-BCDEB8F0-8B0A-4F40-BE47-BD5BCD7B4B13Q33877588-5EEC52CE-65AC-43C4-96AD-C4630938D157Q33913045-220A43B6-0568-4460-BDAD-067E152D3738Q34020377-B01263CD-8F2B-4425-B0DB-129137BC07E4Q34055895-1C570509-52D8-4746-87F3-B6E7DBCA1470Q34072668-9E7F3B88-7EE9-40C8-9F85-6EEDE2428E1AQ34128604-5B881117-8934-4B9E-9B10-F2986443BF97Q34258498-A34E1F52-E99E-4A0F-A4AF-DD06C7C35C3CQ34317041-309DC48D-9033-4BA6-874F-6026A460B2CCQ34572533-AF36933B-BCE6-4C08-A347-76046435DC75Q34575767-95479F24-921B-4C4F-8249-71BFBA146C75Q34776110-F632B42D-30CD-4AC9-B1E6-E2455C9DE22BQ34947016-2BE862B4-86ED-484A-9A69-97A8A8EF4592Q35009182-05F03A12-94C0-4F4B-8F0A-DEA7CD28E960Q35013339-D7C6A09F-D215-4728-A1BD-71E8FEA75512Q35046038-B0413C18-D52F-4A2C-90CA-8F87E9B9FB6EQ35080518-DA60F9BB-AD38-4F70-9961-72960A94909EQ35138543-0264D746-6C07-4DB0-8018-F79F3DC5EA7BQ35169158-948E75E5-7406-464B-8C9B-3906744F3765Q35171620-C807C196-A9E7-453A-8F35-D2F66B2F2FD8Q35192615-CA8D8B87-D14B-4E5B-B8E7-5EB18C7A85A6Q35565760-21EAFE5B-9CE3-40FA-9DC8-D24A89F31D9B
P2860
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@ast
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@en
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@nl
type
label
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@ast
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@en
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@nl
prefLabel
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@ast
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@en
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
@en
P2093
Antoney Ferrey
Brian Culp
Douglas J Winton
Gustavo Leone
Hui-Zi Chen
James M Pipas
Jean-Leon Chong
Louise Mezache
M Teresa Sáenz-Robles
Michael L Robinson
P2860
P2888
P304
P356
10.1038/NATURE08677
P407
P577
2009-12-01T00:00:00Z